期刊文献+

CCL20基因敲低型组织工程皮肤种子细胞的克隆筛选及其干扰效果 被引量:3

Clone screening and interference efficiency of seed cells with CCL20 gene knockdown for tissueengineered skin
原文传递
导出
摘要 目的采用重组慢病毒CCL20基因特异性shRNA载体感染人永生化角质形成细胞系(HaCaT),筛选出稳定干扰CCL20基因表达的细胞克隆并检测其干扰效果。方法用CaCl2法将已构建好的3种pHSER—CCL20-shRNA—GFP载体(pHCG-1和pHCG-2为CCL20基因特异性,pHCG-3为CCL20基因错配)转染293FT包装出慢病毒颗粒,流式细胞术测定其病毒滴度。用G418压力筛选慢病毒感染的HaCaT,荧光定量RT—PCR和ELISA法分别检测CCL20基因mRNA和蛋白的表达水平,以判断其特异性干扰效果。结果三种慢病毒载体所包装出的慢病毒滴度分别为7.08×10^5转导单位(TU)/ml、1.88×10^5TU/ml和2.08×10^5TU/ml;感染后的HaCaT经过G418筛选5~8周,获得4株CCL20基因特异性的细胞克隆(HaCaT-1、HaCaT-2、HaCaT-3和HaCaT-4)及2株CCL20基因错配对照的细胞克隆(HaCaT-5和HaCaT-6)。经荧光定量PCR和ELISA法检测显示,4株CCL20基因特异性细胞克隆均具有稳定干扰效果,不仅能显著地下调CCL20基因的mRNA表达(其抑制率分别为81.0%、89.0%、81.3%、77.2%),而且明显地减少CCL20蛋白分泌(其抑制率分别为70.0%、86.1%、88.1%、90.7%)。结论采用重组慢病毒CCL20基因特异性shRNA载体感染HaCaT可以筛选出具有长期稳定表达RNA干扰效应的CCL20基因敲低型人永生化角质形成细胞克隆,将可能为低免疫排斥反应异基因组织工程皮肤的构建提供种子细胞。 Objective To screen stable cell clones of CCL20 gene knockdown and assess their interference effects, recombinant lentivirus vectors with CCL20 gene specific shRNA were applied to infect human immortal keratinocyte line (HaCaT). Methods The three pHSER-CCL20-shRNA-GFP vectors (pHCG-1 and pHCG-2 were CCL20 gene specific, and pHCG-3 was used as mismatch control) have been previously constructed. The virus packaging cell line 293FT was transfected with these vectors by using CaCl2 methods to produce lectiviral particles. After the viral titers of these three harvested cell supernatants were determined by flow cytometry, HaCaT cells were transfected by these viruses and screened under the pressure of G418. The CCL20 mRNA from HaCaT cell clones and the CCL20 protein levels in the supernatants of HaCaT cell clones were detected by Real-time RT-PCR and ELISA, respectively. Results The titers of three lentiviruses were 7.08 × 10^5 transduced units(TU)/ml, 1.88 ×10^5 TU/ml and 2. 08 × 10^5 TU/ml, respectively. Two HaCaT cell clones from each lectiviral vectors were obtained after G418 screening for 5-8 weeks. Four CCL20 gene specific clones showed stable interference effect in both Real-time RT-PCR and ELISA. The mRNA expression and protein level of CCL20 gene specific clones were down regulated significantly. Conclusions The four human immortal keratinoeyte clones with long term CCL20 gene knockdown have been screened by recombinant lentivirus vectors with CCL20 gene specific shRNA. These clones might be served as seed cells for novel tissue-engineered skin with lower rejection.
出处 《中华外科杂志》 CAS CSCD 北大核心 2009年第8期621-624,共4页 Chinese Journal of Surgery
基金 国家自然科学基金资助项目(30471679) 国家重点基础研究发展计划资助项目(2005CB522605) 国家高技术研究发展计划资助项目(2006AA02A121)
关键词 RNA干扰 慢病毒属 组织工程 种子细胞 RNA interference Lentivirus Tissue engineering Seed cells
  • 相关文献

参考文献11

  • 1Hultman CS, Hunt JP, Yamamoto H, et al. Immunogenicity of cultured keratinocyte allografts deficient in major histocompatibility complex antigens. J Trauma, 1998,45:25-33.
  • 2岳海岭,彭代智.CCL20的结构与功能[J].免疫学杂志,2004,20(z1):100-102. 被引量:14
  • 3朱崇涛,彭代智,潘峰,罗婧,罗海水,王勇,周新,刘敬.人永生化角朊细胞表达干细胞表型的流式细胞术分析[J].现代生物医学进展,2007,7(4):499-503. 被引量:4
  • 4Boukamp P, Petrussevska RT, Breitkreutz D, et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol, 1988,106:761-771.
  • 5董征学,彭代智,刘敬,周新,田易,李芳,严泉,林恒,王勇,周光前.人CCL20基因特异性shRNA重组慢病毒表达载体的构建及测序[J].第三军医大学学报,2006,28(10):1007-1009. 被引量:2
  • 6Wang F, Li SS, Segersvard R, et al. Hypoxia inducible factor-1 mediates effects of insulin on pancreatic cancer cells and disturbs host energy homeostasis. Am J Pathol,2007,170 : 469-477.
  • 7Lizee G, Aerts JL, Gonzales MI, et al. Real-time quantitative reverse transcriptase polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression. Hum Gene Ther, 2003, 14:497-507.
  • 8Boukamp P, Stanbridge E J, Foo DY, et al. c-Ha-ras oncogene expression in immortalized human keratinocytes ( HaCaT ) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res, 1990, 50:2840-2847.
  • 9Dieu-Nosjean MC, Massacrier C, Homey B, et al. Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in altracting Langerhans cell precursors. J Exp Med,2000, 192: 705-718.
  • 10Morris KV, Rossi JJ. Lentiviral-mediated delivery of siRNAs for antiviral therapy. Gene Ther, 2006, 13: 553-558.

二级参考文献32

  • 1岳海岭,彭代智.CCL20的结构与功能[J].免疫学杂志,2004,20(z1):100-102. 被引量:14
  • 2[2]McColl SR. Chemokines and dendritic cells: a crucial alliance[J]. Immunol Cell Biol, 2002 , 80 (5) : 489-496.
  • 3[3]Wolpe SD, Davatelis G, Sherry B, et al. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties [J]. J Exp Med, 1988 ,167(2): 570- 581.
  • 4[4]Schutyser E, Struyf S, Menten P, et al. Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3 alpha from normal and transformed cells [J]. J Immunol, 2000,165 (8): 4470-4477.
  • 5[5]Hieshima K, Imai T, Opdenakker G, et al. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver [J]. J Biol Chem, 1997, 272 (9) : 5 846-5 853.
  • 6[6]Nelson RT, Boyd J, Gladue RP, et al. Genomic organization of the CC chemokine MIP-3/CCL20/LARC/Exodus/SCYA20,showing gene structure, splice variants, and chromosome localization[J]. Genomics, 2001, 73 (1) : 28-37.
  • 7[7]Hoover DM, Boulegue C, Yang D, et al. The structure of human macrophage inflammatory protein-3α / CCL20 [J].J Biol Chem, 2002, 277 (40) : 37 647 - 37 654.
  • 8[8]Caux C, Vanbervliet B, Massacrier C, et al. Regulation of dendric cell recruitment by chemokines [J]. Transplantation,2002,73 (1 Suppl) :S7- S11.
  • 9[9]Charbonnier AS , Kohrgruber N , Kriehuber E , et al . Macrophage inflammatory protein 3 alpha is involved in the constitutive trafficking of epidermal Langerhans cells [J]. J Exp Med, 1999,190 (12) : 1 755- 1 767.
  • 10[10]Iwasaki A, Kelsall BL. Localization of distinct Peyer's Patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP-3α), MIP-3β and secondary lymphoid organ chemokine [ J]. J Exp Med, 2000,191 (8): 1 381- 1 393.

共引文献15

同被引文献40

  • 1岳海岭,彭代智.CCL20的结构与功能[J].免疫学杂志,2004,20(z1):100-102. 被引量:14
  • 2刘博,苏乔,汤敏谦,袁晓东,安利佳.应用于染色体步移的PCR扩增技术的研究进展[J].遗传,2006,28(5):587-595. 被引量:33
  • 3朱崇涛,彭代智,潘峰,罗婧,罗海水,王勇,周新,刘敬.人永生化角朊细胞表达干细胞表型的流式细胞术分析[J].现代生物医学进展,2007,7(4):499-503. 被引量:4
  • 4Boukamp P, Pecrussvskart RT, Breickreuz D, et al. Normal keratinization in a spontaneoualy immortalized aneuploid human keratinocyte cell line, J Cell Biol, 1988, 106(3): 761-771.
  • 5Gius DR, Ezhevsky SA, Becker-Hapak M, et al. Transduced p16^INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late Gl, Cancer Res, 1999, 59(11): 2577- 2580.
  • 6Kim AH, Puram SV, Bilimoria PM, et al. A centrosomal Cdc20- APC pathway controls dendrite morphogenesis in postmitotic neurons, Cell, 2009, 136(2): 322-336.
  • 7Kaur P, Li A. Adhensive properties of human basal epidermal cells: an analysis of keratinocyte stem cells, transit amplifying ceils, and postmitotic differentiating cells, J Invest Dermatol, 2000, 114(3): 413-420.
  • 8Li A, Simmons PJ, Kaur P. Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype, Proc Natl Acad Sci USA, 1998, 95(7): 3902-3907.
  • 9Tani H, Morris RJ, Kaur P. Enrichment for murine keratiuocyte stem cells based on cell surface phenotype, Proc Natl Acad Sci USA, 2000, 97(20): 10960-10965.
  • 10Lorenz K, Rupf T, Salvetter J, et al. Enrichment of human β1^bri/ α6^bri/CD71^dim keratinocytes after culture in defined media, Cells Tissues Organs, 2009, 189(6): 382-390.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部